Cell Reports · 2014 · 60 citations · 34 references
MedicineCancer BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingOncogenic Signaling PathwaysSignal Transduction In CancerTranscription Factor OncogenesTumor Suppressor Gene InactivationTumor Suppressor GenesCancer Signaling PathwaysOncogenic Signaling NetworksOncogenic TransformationP53 Pathway InactivationTriple-negative Breast Cancer TherapyTumor Suppression PathwaysTumor Suppressor P53Tumor Suppressor Pathways
The ARF and p53 tumor suppressors are thought to act in a linear pathway to prevent cellular transformation in response to various oncogenic signals. Here, we show that loss of p53 leads to an increase in ARF protein levels, which function to limit the proliferation and tumorigenicity of p53-deficient cells by inhibiting an IFN-β-STAT1-ISG15 signaling axis. Human triple-negative breast cancer (TNBC) tumor samples with coinactivation of p53 and ARF exhibit high expression of both STAT1 and ISG15, and TNBC cell lines are sensitive to STAT1 depletion. We propose that loss of p53 function and subsequent ARF induction creates a selective pressure to inactivate ARF and propose that tumors harboring coinactivation of ARF and p53 would benefit from therapies targeted against STAT1 and ISG15 activation.
34
Comprehensive genomic characterization of squamous cell lung cancers
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Joan E. Durbin, Renée Hackenmiller, M. Celeste Simon et al. · Cell · 1996 · 1.6K citations · Full text
Life Sciences, Genetics, Immunology +17
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Takehiko Kamijo, Frédérique Zindy, Martine F. Roussel et al. · Cell · 1997 · 1.6K citations · Full text